David Pascoe

David Pascoe started the Rosacea Support Group in October 1998.

Epsolay approved by the FDA for rosacea

Epsolay approved by the FDA for rosacea

Galderma has announced that Epsolay has been approved by the FDA for treating rosacea. Epsolay is a proprietary cream formulation of benzoyl peroxide, 5%, designated for the treatment of inflammatory lesions of rosacea in adults. In July 2021 Galderma announced an exclusive 5 year deal to market Epsolay in the US. The creators of Epsolay […]

Continue Reading

Minolira for the treatment of rosacea

Written by on January 19, 2022 in Acne Treatments, Minocycline, Minolira, tetracyclines with 1 Comment
Minolira for the treatment of rosacea

In 2017, the FDA approved the extended release formulation of minocycline, known as Minolira, for the treatment of severe acne vulgaris. The modified release formulation of doxycycline known as Oracea, was approved for the treatment of rosacea in 2006. As minocycline and doxycycline are related tetracyclines, Minolira may offer rosacea sufferers another rosacea treatment option, […]

Continue Reading

It started with uncomfortable contact lenses

Written by on July 13, 2021 in My Rosacea Story, Ocular Rosacea with 5 Comments
It started with uncomfortable contact lenses

This account of a struggle with getting diagnosed and then dealing with ocular rosacea is worth a read. The struggle is ongoing and we wish you all the best Darelle. Ocular Rosacea Is A Real Thing, And It Sucks My struggle with ocular rosacea began 18 months ago, when I first noticed some discomfort with […]

Continue Reading

Epsolay gets boost from Galderma deal

Epsolay gets boost from Galderma deal

The yet to be approved `encapsulated’ Benzoyl Peroxide 5% Cream known as Epsolay has received a huge promotional boost after the rosacea heavyweight Galderma announced a 5 year exclusive license for the US market. Having the backing of a significant licensing deal from Galderma behind them is good news for the owners of Epsolay. The […]

Continue Reading

Teva Generics announces Generic Soolantra

Teva Generics announces Generic Soolantra

Teva Generics has announced that they are now selling a generic version of Soolantra, branded as Ivermectin Cream 1%. This generic formulation of Ivermectin is indicated for the treatment of inflammatory lesions of rosacea – that is the papules and pustules common to rosacea sufferers. Teva Announces the U.S. Launch of its Generic Version of […]

Continue Reading

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.